Patents Examined by Qiuwen Mi
  • Patent number: 11464249
    Abstract: Use of a lentil product to increase the bioavailability of non-haem iron in a composition comprising one or more anti-nutritional factors.
    Type: Grant
    Filed: May 8, 2019
    Date of Patent: October 11, 2022
    Assignee: Societe des Produits Nestle S.A.
    Inventors: Catherine Mace, Magalie Sabatier, Yassaman Shahkhalili Dulloo, Carmen Tudorica
  • Patent number: 11464746
    Abstract: This invention provides a method for preparing electrospraying particles to improve stability of polyphenol including the following steps: preparing a pectin-silica composite; adding polyphenolic compounds into the pectin-silica composite to prepare a core solution; and coaxial electrospraying the core solution and a shell solution to prepare electrospraying particles loaded polyphenol. This method utilizes a pectin-silica composite as a polyphenol loading carrier, improves the encapsulating efficiency of polyphenols, reduces the contact probability of polyphenols with oxygen and water, and improves the stability of polyphenols; and an acidic aqueous solution is used as a shell solution to synergize with the pectin-silica composite to further improve the stability of polyphenols.
    Type: Grant
    Filed: May 22, 2019
    Date of Patent: October 11, 2022
    Assignee: Zhejiang University of Technology
    Inventors: Ping Shao, Ben Niu, Ligang Jiang
  • Patent number: 11464821
    Abstract: The present invention relates to a composition for preventing and treating cancer-related fatigue, characterized by containing a new processed ginseng powder or a new processed ginseng extract having an increased amount of a ginsenoside constituent, which was previously minute, by preparing a saponin-decomposing enzyme and subsequently using hydrolysis by the prepared saponin-decomposing enzyme and an organic acid. The composition according to the present invention can be very effectively used for preventing and treating cancer-related fatigue, the most destructive and universal side effect, which is caused by cancer itself or occurs in association with the treatment of cancer.
    Type: Grant
    Filed: June 4, 2020
    Date of Patent: October 11, 2022
    Assignee: GREEN CROSS WELLBEING CORPORATION
    Inventors: Young Hyo Yoo, Jeom Yong Kim, Joo Young Kim, Sun Kyu Park
  • Patent number: 11464827
    Abstract: The present disclosure provides compositions comprising combinations of one or more lectins, sulfated polysaccharides from marine algae, and cannabinoids and a pharmaceutically acceptable excipient or mixtures of excipients and methods of preparing such compositions.
    Type: Grant
    Filed: March 10, 2021
    Date of Patent: October 11, 2022
    Assignee: Anewsha Holding Group LLC
    Inventor: Chris Thomas Swartout
  • Patent number: 11457650
    Abstract: A formulation and a composition that comprises it for promoting the pollination of almond tree crops (Prunus dulcis) by biasing the foraging preferences of the honey bee (Apis mellifera). The formulation comprises the compounds limonene, linalool and benzaldehyde. Additionally, a method for targeting the bees' pollinizing activity towards the almond tree crops by using the formulation comprising the compounds limonene, linalool and benzaldehyde.
    Type: Grant
    Filed: July 25, 2018
    Date of Patent: October 4, 2022
    Assignees: CONSEJO NACIONAL DE INVESTIGACIONES CIENIIFICAS Y TECNICAS (CONICET), UNIVERSIDAD DE BUENOS AIRES
    Inventors: Walter M. Farina, Maria Cecilia Estravis Barcala, Florencia Palottini
  • Patent number: 11452755
    Abstract: The present invention includes a method of using PHY906 for treating a bowel disorder including inflammatory bowel disease and irritable bowel syndrome. Particularly, the present invention provides a multiple symptoms treatment for the bowel disorder.
    Type: Grant
    Filed: October 29, 2020
    Date of Patent: September 27, 2022
    Assignee: YALE UNIVERSITY
    Inventors: Yung-Chi Cheng, Shwu-Huey Liu, Robert Tilton
  • Patent number: 11452686
    Abstract: The invention relates to a particular cosmetic active substance that is constituted through bioconversion by Lactobacillus arizonensis of its original substrate, Simmondisia chinens. The invention also relates to a preparation method, to compositions comprising same, and to uses thereof for cosmetic applications.
    Type: Grant
    Filed: September 1, 2020
    Date of Patent: September 27, 2022
    Assignee: SOCIETE INDUSTRIELLE LIMOUSINE D'APPLICATION BIOLOGIQUE
    Inventor: Jean Paufique
  • Patent number: 11446232
    Abstract: The invention relates to a personal care product for alleviating skin dryness, including facial skin dryness, body dryness, and breast skin dryness and for use as a massage oil. Embodiments of the personal care product include a formulation including cocoa butter, kokum butter, shea olein, and hyaluronic acid and/or cannabis oil. The personal care product may also include other plant-based glycerides, natural hormones, herbal roots and oils, amino acids, dietary supplements. The personal care product is substantially free of added water, alcohol, synthetic chemical, anti-microbial, and synthetic hormone.
    Type: Grant
    Filed: April 10, 2019
    Date of Patent: September 20, 2022
    Assignee: Damiva Inc.
    Inventors: Gardiner F H Smith, Chia Chia Sun
  • Patent number: 11446256
    Abstract: The present invention relates to a water resistant wound cover with high comfort and good air permeability. In particular, the present invention relates to an aqueous wound healing formulation comprising a water-soluble or a water-dispersible polymeric material that does not sting when applied to a minor injury to the skin.
    Type: Grant
    Filed: August 20, 2021
    Date of Patent: September 20, 2022
    Assignee: ADVANTICE HEALTH, LLC
    Inventors: Hellen Spanjer, Kathryn Jill Rivera, Stephen Maida, Joseph Librizzi, Anthony D'Ovidio
  • Patent number: 11446347
    Abstract: Provided are an antithrombotic composition (platelet aggregation inhibitor) comprising an Angelica gigas Nakai extract and a pharmaceutical composition for prevention and/or treatment of vascular disease, which comprises an Angelica gigas Nakai extract. The compositions are characterized in that they do not cause a gastrointestinal disorder.
    Type: Grant
    Filed: May 13, 2019
    Date of Patent: September 20, 2022
    Assignee: ASTROGENESIS CO., LTD.
    Inventors: Kang Hyun Lee, Min Kuk
  • Patent number: 11446233
    Abstract: Cosmetic compositions comprising high amount of Silybum marianum Extract, relatively high amounts of skin active ingredients chosen from salicylic acid, ascorbic acid, a cinnamic acid derivative, or a mixture thereof; c) one or more surfactants; d) from about 3 to about 15 wt. % of Propylene Glycol; e) from about 5 to about 18 wt. % of Dipropylene Glycol; and f) water; and wherein the composition has a pH not higher than about 5.
    Type: Grant
    Filed: September 30, 2020
    Date of Patent: September 20, 2022
    Assignee: L'OREAL
    Inventors: Patricia Brieva, Stephen Matthew Lynch, Maggie Su, Madeline Jane Sverdlove, Ashleigh Nichole Murtaugh-Frey, Angelike Galdi
  • Patent number: 11432567
    Abstract: The present invention relates to a powder made of insects, for use in the prevention or reduction of stress in fish being farmed.
    Type: Grant
    Filed: September 5, 2018
    Date of Patent: September 6, 2022
    Assignee: YNSECT
    Inventors: Constant Motte, Benjamin Armenjon
  • Patent number: 11433019
    Abstract: A method for preparing Ganoderma lucidum extract using an eco-friendly extraction technique is disclosed. A Ganoderma lucidum extract prepared thereby and a cosmetic composition containing the extract, and their uses are disclosed. The extraction technique use an aqueous cyclodextrin solution alone or in combination with ultrasonic extraction to afford a Ganoderma lucidum extract containing a high concentration of the effective ingredient triterpenoid.
    Type: Grant
    Filed: September 20, 2018
    Date of Patent: September 6, 2022
    Assignee: AMOREPACIFIC CORPORATION
    Inventors: Jin Sup Shim, Eun Jung Lee, Nok Hyun Park, So Woong Choi, Yong Jin Kim
  • Patent number: 11433095
    Abstract: Engineered food to promote health and maintain homeostasis in a subject and methods of producing the food.
    Type: Grant
    Filed: March 26, 2021
    Date of Patent: September 6, 2022
    Assignee: VECTOR VITALE IP LLC
    Inventors: Peter Y. Novak, Maxim V. Temnikov
  • Patent number: 11426365
    Abstract: The present invention provides a composition comprising a synergistic combination of thymoquinone and one or more omega-3 fatty acids, wherein the molar ratio between said thymoquinone and said one or more omega-3 fatty acids is at least 1:7. The present invention also provides a method of using said composition to treat or prevent inflammatory conditions.
    Type: Grant
    Filed: July 15, 2018
    Date of Patent: August 30, 2022
    Assignee: Trinutra Ltd.
    Inventors: Yoram Sela, Mor Zeilkha, Itschak Lamensdorf
  • Patent number: 11419848
    Abstract: The present invention relates to a composition for the protection, treatment and repair of cartilage in humans and animal joints. The composition contains a combination of unsaponifiable lipids together with one or more of polyphenols and/or catechins. The composition or kit may contain avocado:soybean unsaponifiables (ASU) and green tea.
    Type: Grant
    Filed: August 19, 2020
    Date of Patent: August 23, 2022
    Assignee: NUTRAMAX LABORATORIES, INC.
    Inventors: Todd R. Henderson, Louis Lippiello, Charles Filburn, David Griffin
  • Patent number: 11419815
    Abstract: Disclosed is a method of treating inflamed skin of a periorbital area of a person's face. The method can include topically applying to inflamed skin a composition comprising an oil extract of Opuntia ficus-indica tuna, Opuntia ficus-indica nopales, or a combination thereof, to reduce inflammation in skin cells of the periorbital area of the person's face.
    Type: Grant
    Filed: November 16, 2020
    Date of Patent: August 23, 2022
    Assignee: MARY KAY INC.
    Inventors: Michelle Hines, Geetha Kalahasti, Tiffany Florence, David Gan
  • Patent number: 11413308
    Abstract: Methods and compositions for treating and/or preventing aging-related conditions are described. The compositions used in the methods include blood plasma and blood plasma fractions derived from blood plasma with efficacy in treating and/or preventing aging-related conditions such as cognitive disorders. The methods relate to a regimen of pulsed dosing of blood plasma or blood plasma fractions.
    Type: Grant
    Filed: November 13, 2020
    Date of Patent: August 16, 2022
    Assignee: Alkahest, Inc.
    Inventors: Steven P. Braithwaite, Eva Czirr, Ian Gallager, Nina Huber, S. Sakura Minami
  • Patent number: 11400043
    Abstract: Methods of use and compositions useful for reducing lines and wrinkles, evening skin tone, lightening skin tone, increasing skin radiance, elasticity, skin barrier function, and/or skin firmness, reducing photodamage, reducing sagging skin, inhibiting anti-oxidant capacity in skin, MMP-1, MMP-3, MMP-9, pro-inflammatory cytokines (e.g., lipoxygenase, IL-6, Il-8, TNF-?, or VEGF), and/or elastase expression in skin, and/or increasing collagen expression in skin, elastin expression in skin, laminin expression in skin, and/or fibronectin expression in skin are disclosed herein. The compositions can additionally reduce or mitigate unwanted side effects shown in other retinol products such as erythema or redness in skin, skin dryness, peeling or flaking of skin, and/or skin irritation including without limitation, burning, stinging, itching, or tingling.
    Type: Grant
    Filed: December 10, 2020
    Date of Patent: August 2, 2022
    Assignee: MARY KAY INC.
    Inventors: Geetha Kalahasti, Patricia Jacoby, Milagros Sanchez, Shona Burkes-Henderson, David Gan
  • Patent number: 11400126
    Abstract: Provided are compositions including at least one Dead Sea extract and at least one extract of the Apple of Sodom (Calotropis procera). Further provided are formulations including the compositions and their uses.
    Type: Grant
    Filed: December 26, 2018
    Date of Patent: August 2, 2022
    Assignee: AHAVA—DEAD SEA LABORATORIES LTD.
    Inventors: Meital Portugal Cohen, Zeevi Maor, Eliran Ish-Shalom, Dror Cohen